The Company uses Moores Cancer Center at the University of California San Diego (UCSD) to provide pharmacology lab services to the Company. Dr. Stephen Howell is the Acting Chief Medical Officer of Aptose and is also a Professor of Medicine at UCSD and oversees the laboratory work. The work is completed under the terms of research services agreements executed in and has been extended annually. In the Board approved an extension of this agreement for months for services up to These transactions are in the normal course of business and are measured at the amount of consideration established and agreed to by the related parties.

 

During year ended the Company recorded thousand ( – thousand) in research and development expenses related to the agreement.